4.6 Article

The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trials

Jocelyn K. Tamura et al.

Summary: Cognitive impairment is common in bipolar disorder, but currently there is no intervention that has demonstrated significant pro-cognitive effects in adults with bipolar disorder. Future trials may consider targeting interventions to specific cognitive subgroups and utilizing biomarkers of cognitive function.

CNS SPECTRUMS (2022)

Review Behavioral Sciences

The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research

Hartej Gill et al.

Summary: Research suggests that intravenous ketamine may have positive effects on cognition in TRD patients, including improvements in working memory and visual learning memory, although symptoms in anxious TRD participants may show more significant improvement.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

Review Clinical Neurology

Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review

Jason Ng et al.

Summary: The review and synthesis of existing literature on functional outcomes with ketamine/esketamine treatment in adults with treatment-resistant depression suggest mixed results across different functional measures, with improvements in general psychosocial functioning apparent. Future research is needed to explore the association between symptomatic improvement and functional improvement in TRD.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Review Medicine, Research & Experimental

Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant Depression

Eric P. McMullen et al.

Summary: This systematic review aimed to identify strategies capable of prolonging the acute efficacy of ketamine in adults with treatment-resistant depression. The study found that, other than repeat-dose IV ketamine, no treatment modality has demonstrated the ability to significantly prolong the acute efficacy of IV ketamine in TRD.

ADVANCES IN THERAPY (2021)

Article Psychiatry

Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

Roger S. McIntyre et al.

Summary: Replicated international studies have highlighted the human and societal costs of major depressive disorder, with monoamine-based antidepressants proving effective but many patients failing to fully recover. Ketamine and esketamine offer novel pharmacological treatments for treatment-resistant depression, but questions remain about their safety and effectiveness. International experts provide guidance on the use of these agents, while discussing areas of consensus and future research directions.

AMERICAN JOURNAL OF PSYCHIATRY (2021)

Article Psychiatry

Cortical haemodynamic response during the verbal fluency task in patients with bipolar disorder and borderline personality disorder: a preliminary functional near-infrared spectroscopy study

Syeda Fabeha Husain et al.

Summary: Prefrontal cortex activity is disrupted in patients with BD and BPD, but it is more extensive in BPD. These results provide further neurophysiological evidence for the separation of BPD from the bipolar spectrum. fNIRS could be a potential tool for assessing the frontal lobe function of patients who present with symptoms that are common to BD and BPD.

BMC PSYCHIATRY (2021)

Article Psychiatry

The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE)

Roger S. McIntyre et al.

Summary: The study found that intravenous ketamine can significantly improve cognitive function in TRD patients, especially in tests like DSST and PDQ-5-D. This improvement is mainly mediated by reduced depressive symptoms, indicating that ketamine has independent and rapid effects in promoting cognition.

PSYCHIATRY RESEARCH (2021)

Article Multidisciplinary Sciences

Validating a functional near-infrared spectroscopy diagnostic paradigm for Major Depressive Disorder

Syeda Fabeha Husain et al.

SCIENTIFIC REPORTS (2020)

Article Clinical Neurology

A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression

Wei Zheng et al.

JOURNAL OF AFFECTIVE DISORDERS (2020)

Article Psychiatry

Cognitive impairment in chronic ketamine abusers

Chenxi Zhang et al.

PSYCHIATRY RESEARCH (2020)

Article Medicine, General & Internal

Bipolar disorders

Roger S McIntyre et al.

LANCET (2020)

Review Clinical Neurology

Neurocognitive impact of ketamine treatment in major depressive disorder: A review on human and animal studies

Camilla Crisanti et al.

JOURNAL OF AFFECTIVE DISORDERS (2020)

Article Clinical Neurology

Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder

Wei Zheng et al.

JOURNAL OF AFFECTIVE DISORDERS (2019)

Review Biochemistry & Molecular Biology

Mechanisms of ketamine action as an antidepressant

P. Zanos et al.

MOLECULAR PSYCHIATRY (2018)

Article Psychology, Developmental

Cognitive flexibility and performance in children and adolescents with threshold and sub-threshold bipolar disorder

Daniel P. Dickstein et al.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2016)

Review Clinical Neurology

Computerized cognitive training and functional recovery in major depressive disorder: A meta-analysis

Jeffrey N. Motter et al.

JOURNAL OF AFFECTIVE DISORDERS (2016)

Article Biochemistry & Molecular Biology

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

Ronald S. Duman et al.

NATURE MEDICINE (2016)

Article Clinical Neurology

Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression

Paulo R. Shiroma et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)

Article Clinical Neurology

A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults

Roger S. McIntyre et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)

Article Psychiatry

Verbal learning and memory in depression: A 9-year follow-up study

Marianne Halvorsen et al.

PSYCHIATRY RESEARCH (2011)

Article Psychology, Clinical

Effects of Lithium on Cognitive Performance: A Meta-Analysis

Aliza P. Wingo et al.

JOURNAL OF CLINICAL PSYCHIATRY (2009)

Article Neurosciences

Antidepressant effects of ketamine in depressed patients

RM Berman et al.

BIOLOGICAL PSYCHIATRY (2000)